|
Feb 26
|
Is Aurora Cannabis (ACB) Stock Outpacing Its Medical Peers This Year?
|
|
Feb 25
|
Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know
|
|
Feb 21
|
Best Momentum Stocks to Buy for February 21st
|
|
Feb 21
|
Best Value Stocks to Buy for February 21st
|
|
Feb 20
|
Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia
|
|
Feb 12
|
Aurora Cannabis Skyrockets After Earnings: Should You Buy Into the Rally?
|
|
Feb 10
|
All You Need to Know About Aurora Cannabis (ACB) Rating Upgrade to Strong Buy
|
|
Feb 10
|
Is Beam Therapeutics (BEAM) Outperforming Other Medical Stocks This Year?
|
|
Feb 7
|
Aurora Cannabis Announces Supply Agreement with SNDL
|
|
Feb 6
|
Aurora Cannabis Third Quarter 2025 Earnings: EPS: CA$0.57 (vs CA$0.51 loss in 3Q 2024)
|
|
Oct 9
|
Is It Time to Load Up on Aurora Cannabis Stock?
|
|
Oct 3
|
ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project
|
|
Oct 2
|
Aurora Cannabis Down Slightly in U.S. Pre-Market After Reporting Project Collaboration Focused on Distinct Cannabis Aromas
|
|
Oct 2
|
Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas
|
|
Sep 20
|
Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors
|
|
Aug 27
|
NASDAQ Cannabis Titan, Aurora, Could Boost 31% Sales Surge With This New CBD Lozenge Partnership
|
|
Aug 24
|
Prediction: Aurora Cannabis Will Be Worth More Than Canopy Growth in 5 Years
|
|
Jul 30
|
Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2024 Annual General and Special Meeting of Shareholders
|
|
Jul 29
|
Aurora Cannabis to Host First Quarter 2025 Investor Conference Call
|
|
Jul 25
|
Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility
|